SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-018437
Filing Date
2018-08-01
Accepted
2018-08-01 16:05:34
Documents
4
Period of Report
2018-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20180730.htm 8-K 60585
2 EX-10.1 life-ex101_6.htm EX-10.1 39553
3 GRAPHIC g3kpazbkcl3z000002.jpg GRAPHIC 7804
4 GRAPHIC g3kpazbkcl3z000001.jpg GRAPHIC 8339
  Complete submission text file 0001564590-18-018437.txt   123977
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 18984752
SIC: 2836 Biological Products, (No Diagnostic Substances)